3 / 38
A QUICK REVIEW ON WHAT NET REPRESENT
Yao JC, et al. J Clin Oncol. 2008;26(18):3063-3072.
Frilling A, et al. Endocr Relat Cancer. 2012;19:R163-R185.
Sackstein P, et al. Seminars Oncology 2018, In press.
Prevalence
M1 at
diagnosis
5 year overall
survival
Small intestine
30,8%
70%
55%
Lung
25%
30%
27%
Colon
17,6%
71%
20%
Pancreatic
12,1%
50-60%
30-50%
Rectum
26,3%
15%
30%
Appendix
5,7%
10%
34%
Grade III
Grade I
Grade II